- Studies with a low overall risk of bias are shaded in grey
- aData were obtained by contacting the author
- b2.5th to 97.5th percentile were stated instead of range
- cMean follow-up in years (range)
- dThe time period and range of follow-up in years were not reported
- eIPS ≥2 (%)
- fthis study also provided median (range) of LMR of healthy control: 3.1 (0.6–4.0)
- Abbreviations: Alb albumin, ALC absolute lymphocyte count, AMC absolute monocyte count, ANC absolute neutrophil count, chemo chemotherapy, EFS event-free survival, Hb haemoglobin, HL Hodgkin’s lymphoma, HR hazard ratios, IPS international prognostic score, LMR lymphocyte-monocyte ratio, LSS lymphoma-specific survival, NLR neutrophil-lymphocyte ratio, NR not reported, OS overall survival, PET positron emission tomography, PFS progression-free survival, RT radiotherapy, TTP time-to-progression, WBC white blood cell count
